PT98780A - Processo de producao de um polipeptido puro ou de um seu derivado possuindo actividade zp3 humana de acidos nucleicos vectores anticorpos composicoes farmaceuticas e vacinas - Google Patents

Processo de producao de um polipeptido puro ou de um seu derivado possuindo actividade zp3 humana de acidos nucleicos vectores anticorpos composicoes farmaceuticas e vacinas Download PDF

Info

Publication number
PT98780A
PT98780A PT98780A PT9878091A PT98780A PT 98780 A PT98780 A PT 98780A PT 98780 A PT98780 A PT 98780A PT 9878091 A PT9878091 A PT 9878091A PT 98780 A PT98780 A PT 98780A
Authority
PT
Portugal
Prior art keywords
polypeptide
human
sequence
antibodies
vector
Prior art date
Application number
PT98780A
Other languages
English (en)
Portuguese (pt)
Inventor
Marcel Van Duin
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of PT98780A publication Critical patent/PT98780A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT98780A 1990-08-27 1991-08-26 Processo de producao de um polipeptido puro ou de um seu derivado possuindo actividade zp3 humana de acidos nucleicos vectores anticorpos composicoes farmaceuticas e vacinas PT98780A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90202287 1990-08-27

Publications (1)

Publication Number Publication Date
PT98780A true PT98780A (pt) 1992-07-31

Family

ID=8205102

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98780A PT98780A (pt) 1990-08-27 1991-08-26 Processo de producao de um polipeptido puro ou de um seu derivado possuindo actividade zp3 humana de acidos nucleicos vectores anticorpos composicoes farmaceuticas e vacinas

Country Status (12)

Country Link
JP (1) JPH06500690A (ja)
KR (1) KR930702522A (ja)
CN (1) CN1060499A (ja)
AU (1) AU8328591A (ja)
CA (1) CA2090486A1 (ja)
FI (1) FI930897L (ja)
HU (1) HUT64394A (ja)
IE (1) IE912872A1 (ja)
NZ (1) NZ239518A (ja)
PT (1) PT98780A (ja)
WO (1) WO1992003548A1 (ja)
ZA (1) ZA916432B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
AU9094191A (en) * 1990-11-21 1992-06-25 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1994010304A1 (en) * 1992-11-02 1994-05-11 Akzo Nobel N.V. Marmoset zona pellucida protein zp3
US6001599A (en) * 1992-11-09 1999-12-14 Zonagen, Inc. DNAs encoding mammalian ZPBs
DE69333610D1 (de) * 1992-11-09 2004-10-07 Zonagen Inc Methoden für die immunoempfängnisverhütung
AU3471395A (en) * 1994-08-22 1996-03-14 Akzo Nobel N.V. New immunocontraceptive peptides
DE19622289A1 (de) * 1996-05-23 1997-11-27 Schering Ag Zona Pellucida Proteine zur Kontrazeption
BR9908096A (pt) * 1998-02-19 2000-10-31 Eastern Virginia Med School Proteìna 3 da zona pelúcida humana (hzp3), ativa, recombinante
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
EP1421104A4 (en) 2001-08-02 2005-08-24 Trinity Biomedical Technology HUMANE ZONA PELLUCIDA PROTEINS AND METHOD FOR THEIR USE IN THE DIAGNOSIS OF MALE INFERENCE
CN101906163B (zh) * 2009-06-05 2012-06-27 上海交通大学医学院 一种免疫避孕的合成肽和嵌合肽及其应用
EP3847187A1 (en) * 2018-09-03 2021-07-14 Laboratoire HRA-Pharma Zp3 fragments in immunotherapy of ovarian cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
CA2058999A1 (en) * 1989-06-12 1990-12-13 Jurrien Dean Contraceptive vaccine based on cloned zona pellucida gene

Also Published As

Publication number Publication date
HUT64394A (en) 1993-12-28
FI930897A7 (fi) 1993-04-05
CA2090486A1 (en) 1992-02-28
NZ239518A (en) 1994-03-25
FI930897A0 (fi) 1993-02-26
IE912872A1 (en) 1992-03-11
CN1060499A (zh) 1992-04-22
ZA916432B (en) 1992-06-24
FI930897L (fi) 1993-04-05
WO1992003548A1 (en) 1992-03-05
JPH06500690A (ja) 1994-01-27
KR930702522A (ko) 1993-09-09
AU8328591A (en) 1992-03-17
HU9300537D0 (en) 1993-05-28

Similar Documents

Publication Publication Date Title
Moroianu et al. Mammalian karyopherin alpha 1 beta and alpha 2 beta heterodimers: alpha 1 or alpha 2 subunit binds nuclear localization signal and beta subunit interacts with peptide repeat-containing nucleoporins.
AU684765B2 (en) Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US6264953B1 (en) Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
US5639440A (en) Method for evaluating immunogenicity
CA2211993A1 (en) Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
WO1992003548A1 (en) Human zona pellucida protein zp3
AU636895B2 (en) Contraceptive vaccine based on cloned zona pellucida gene
US7230073B2 (en) Sperm specific proteins
US20040248257A1 (en) SPEX compositions and methods of use
AU782467B2 (en) Egg specific surface proteins
US7125550B2 (en) Human sperm specific lysozyme-like proteins
US6455041B1 (en) Immunogenic epitopes of the human zona pellucida protein (ZP1)
TRZYNA et al. Schistosoma mansoni: genetic non‐response to p40, the major protein antigen of the egg, reveals a novel mechanism enhancing IgM production during infection
HUT77262A (hu) Új immunokontraceptív peptidek
AU743703B2 (en) Method for the production of vaccines against cell surface proteins
WO1994010304A1 (en) Marmoset zona pellucida protein zp3
Buchmeier Synthetic Vaccines for the Control of Arenavirus Infections
AU2004203523A1 (en) Immunocontraceptive compositions containing sperm antigens, and methods of use

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920313

FC3A Refusal

Effective date: 19981029